他汀類藥物調脂外作用在臨床應用的研究進展(參考版)
2024-08-15 13:55本頁面
【正文】 參考文獻[1] world health global burden of disease—2004 update[r].2008.[2 ]american heart association statistics mittee and stroke statistics submittee. executive summary： heart disease and stroke statistics—2010 update： a report from the american heart association[j]. circulation，2010，121（7）：948—954.[3] american diabetes association. standards of medical care in diabetes—2008[j].diabetes care，2008，31（1）：12—54.[4] fuster v，moreno p r，fayad z a，et and high—risk plaque： part i： evolving concepts[j].j am coll cardiol，2005，46（6）：937—954.[5] saiki a，murano t，watanabe f，et enhanced lipoprotein lipase expression in 3t3—l1 preadipocytes[j].j atheroscler thromb，2005，12（3）：163—168.[6] yano m，matsumura t，senokuchi t，et activate peroxisome proliferator—activated receptor gamma through extracellular signal—regulated kinase 1/2 and p38 mitogen—activated protein kinase—dependent cyclooxygenase—2 expression in macrophages[j]. circ res，2007，100（10）：1442—1451.[7] jones p h，davidson m h，stein e a，et of the efficacy and safety of rosuvastatin versus atorvastatin， simvastatin， and pravastatin across doses[j].am j cardiol，2003，92（2）：152—160.[8] shepherd j， cobbe s m，ford i，et of coronary heart disease with pravastatin in men with hypercholesterolemia[j].n engl j med，1995，333（20）：1301—1307.[9] nakamura h，arakawa k，itakura h，et prevention of cardiovascular disease with pravastatin in japan （mega study）： a prospective randomised controlled trial[j].lancet，2006，368（9542）：1155—1163.[10] ridker p m，danielson e，fonseca f a g，et study group. rosuvastatin to prevent vascular events in men and women with elevated c—reactive protein[j]. n engl j med，2008，359（21）：2195—2207.[11] the coordinating mittee of the national cholesterol education of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines[j].circulation，2004，110（2）：227—239.[12] the 4s trial of cholesterol lowering in 4444 patients with coronary heart disease： the scandinavian simvastatin survival study （4s） [j].lancet，1994，344（8934）：1383—1389.[13] sacks f m，pfeffer m a，moye l a，et effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. cholesterol and recurrent events trial investigators[j].n engl j med，1996，335（14）：1001—1009.[14] larosa j c，deedwania p c，shepherd j，et investigators. parison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event （from the treating to new targets [tnt] trial）[j].am j c
環(huán)評公示相關推薦
鄂ICP備17016276號-1